Dr. Geschwind’s expertise in liver cancer is internationally recognized. He has been a lead or co-investigator in over 50 clinical trials aimed at developing innovative therapies, including intra-arterial therapy using radioactive microspheres and noninvasive ultrasound-guided treatment options. These therapies offer hope to patients with liver cancer, a condition often associated wit... https://medicine.yale.edu/news/yale-medicine-magazine/article/jeff-geschwind-md-to-chair-diagnostic-radiology/